Press release2024
Occlutech® Announces Commercial Cases of Occlutech ASD Occluder Device Implantation in the U.S.
Procedures carried out at a number of leading cardiac centers across the country. The Occlutech ASD Occluder is associated with ...
Press release2024
Occlutech® Announces FDA Approval of its Occlutech® ASD Occluder and Occlutech® Pistol Pusher, a Minimally Invasive Cardiac Device and Delivery System to Treat Atrial Septal Defects
Occlutech ASD Occluder delivers positive procedural outcomes with strong efficacy and a low rate of complications Occlutech®, a world leading ...
